Troy Bartron Jr.

Scientist I - Formulation Development at Acorda Therapeutics

Troy Bartron Jr. is an experienced formulation scientist with a robust background in pharmaceutical development and project management. Currently serving as Scientist I - Formulation Development at Acorda Therapeutics, Inc., since July 2022, Troy previously held positions as Senior Formulation Scientist at Pace® Life Sciences and Formulation Scientist at Emerson Resources Inc., where expertise in GMP compliance and clinical trial support was demonstrated. Troy's experience encompasses a wide range of formulation processes, including the development of small molecule dosage forms, management of GMP operations, and the coordination of in-house and client-facing projects. Prior roles included Associate Research Scientist at Specialty Assays Inc., focusing on organic synthesis and enzymatic substrate development, complemented by early experience as a Pharmacy Technician at Wegmans Food Markets. Troy holds a Bachelor of Science in Biochemistry from Moravian University.

Location

Ardmore, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Acorda Therapeutics

1 followers

Acorda Therapeutics is a publicly-traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders.


Industries

Employees

201-500

Links